Active ingredient in magic mushrooms reduces anxiety and depression in cancer patients

December 10, 2015, American College of Neuropsychopharmacology

A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases in anxiety and depression in patients diagnosed with life-threatening cancer according to a new study presented today at the annual meeting of the American College of Neuropsychopharmacology.

Patients who receive a cancer diagnosis often develop debilitating symptoms of anxiety and depression. Reports from the 1960s and 1970s suggest that hallucinogenic drugs such as LSD may alleviate such symptoms in cancer patients, but the clinical value of for the treatment of mood disturbances in remains unclear. In this new study, Roland Griffiths and colleagues from the Johns Hopkins University School of Medicine investigated the effects of psilocybin on symptoms of anxiety and depression in individuals diagnosed with life-threatening cancer. Five weeks after receiving a dose of psilocybin sufficiently high to induce changes in perception and mystical-type experiences, patients reported significantly lower levels of anxiety and depression compared with patients that received a low dose of the drug. The positive effects on mood persisted in the patients at 6 month follow-up.

The authors suggest that a single dose of may be sufficient to produce enduring decreases in negative mood in with a life-threatening cancer.

Explore further: The potential of psilocybin to alleviate psychological distress in cancer patients is revealed

Related Stories

The potential of psilocybin to alleviate psychological distress in cancer patients is revealed

January 31, 2013
Improvements in the diagnosis and treatment of cancers in recent years have led to a marked increase in patients' physical survival rates. While doctors can treat the physical disease, what is not well understood is how best ...

Could psychedelic drugs be good medicine for some?

September 8, 2015
(HealthDay)—In a carefully controlled setting, psychedelic drugs such as LSD or "magic mushrooms" may benefit patients with hard-to-treat anxiety, addiction or post-traumatic stress disorder (PTSD), new research suggests.

Lower survival rates in women with breast cancer diagnosed with depression

December 1, 2015
Women with breast cancer who subsequently had a recorded diagnosis of depression had a 45% higher risk of death from all causes, according to a study led by King's College London. The researchers suggest this finding could ...

Psilocybin inhibits the processing of negative emotions in the brain

May 7, 2014
Emotions like fear, anger, sadness, and joy enable people to adjust to their environment and react flexibly to stress and strain and are vital for cognitive processes, physiological reactions, and social behaviour. The processing ...

Patients awaiting lung transplant commonly suffer depression-related symptoms

October 19, 2015
Researchers from Mayo Clinic in Rochester, Minnesota, have found patients awaiting lung transplant often suffer from stress, anxiety, or depressive symptoms, and these symptoms are not isolated to patients with pre-existing ...

Recommended for you

People are more honest when using a foreign tongue, research finds

August 17, 2018
New UChicago-led research suggests that someone who speaks in a foreign language is probably more credible than the average native speaker.

FDA approves brain stimulation device for OCD

August 17, 2018
(HealthDay)—A brain stimulation device to treat obsessive-compulsive disorder (OCD) has received approval for marketing Friday by the U.S. Food and Drug Administration.

16 going on 66: Will you be the same person 50 years from now?

August 17, 2018
How much do you change between high school and retirement? The answer depends on whether you're comparing yourself to others or to your younger self.

Research eyes role of stress in mental illnesses

August 17, 2018
We all face stress in our lives. Even researchers seeking to understand why some people shrug it off while others face battles against disorders like depression or PTSD.

It's okay when you're not okay: Study re-evaluates resilience in adults

August 16, 2018
Adversity is part of life: Loved ones die. Soldiers deploy to war. Patients receive terminal diagnoses.

Men and women show surprising differences in seeing motion

August 16, 2018
Researchers reporting in the journal Current Biology on August 16 have found an unexpected difference between men and women. On average, their studies show, men pick up on visual motion significantly faster than women do.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.